Mon, Sep 15, 2014, 9:45 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Chesapeake Granite Wash Trust Message Board

thokie1 2 posts  |  Last Activity: Aug 4, 2014 12:04 PM Member since: Feb 23, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • thokie1 by thokie1 Aug 4, 2014 12:04 PM Flag

    FDA valididates company's business plan! Should at least put a floor on stock price, it should only go up from here as sales increase to replace unapproved versions. Next catalyst is to repeat with more drugs. The window is open but for how long is the question? Until other company's duplicate flamels plans and products. Until then increasing profit should result in increased PPS. Buy now!

    Sentiment: Strong Buy

  • The cost of one dose of IV Tylenol is set to increase to $33. This is up from $12 per dose when cadence pharm brought it to market. Because of this increase price my hospital is removing it from the hospital formulary and it will no longer be available. They projected this drug alone would cost the hospital $600,000. I think this will be repeated at many hospitals across the US. This make the purchase price for cadence pharm way to high at 1.4 billion. Stock price should decrease

    Sentiment: Sell

10.76+0.39(+3.76%)Sep 15 4:02 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Avanir Pharmaceuticals, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT
Netflix, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT